This special episode from ACC.18 features an interview with Erik Magnus Ohman, Roger S. Blumenthal, and Philippe Gabriel Steg about Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial.

Subscribe on iTunes | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: Acute Coronary Syndromes, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Interventions and ACS, Interventions and Imaging, Angiography, Nuclear Imaging

Keywords: ACC18, ACC Annual Scientific Session, Acute Coronary Syndrome, Antibodies, Monoclonal, Angina, Unstable, Apolipoproteins B, Brain Ischemia, Cholesterol, HDL, Cholesterol, LDL, Coronary Disease, Cost-Benefit Analysis, Diabetes Mellitus, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Myocardial Infarction, Myocardial Revascularization, Secondary Prevention, Stroke, Treatment Outcome, Metabolic Syndrome, Thoracic Surgery, Heart Failure, Angiography, ACCELLite

< Back to Listings